Dissemin is shutting down on January 1st, 2025

Published in

American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 12(65), 2021

DOI: 10.1128/aac.01249-21

Links

Tools

Export citation

Search in Google Scholar

Antifungal Susceptibility Testing Identifies the Abdominal Cavity as a Source of Candida glabrata-Resistant Isolates

Journal article published in 2021 by Judith Díaz-García ORCID, Aina Mesquida ORCID, Ana Gómez ORCID, Marina Machado ORCID, Pablo Martín-Rabadán, Luis Alcalá, Carlos Sánchez-Carrillo, Elena Reigadas ORCID, Teresa Vicente, Patricia Muñoz ORCID, Pilar Escribano ORCID, Jesús Guinea ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Orange circle
Published version: archiving restricted
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

To identify unrecognized niches of resistant Candida isolates and compartmentalization, we retrospectively studied the antifungal susceptibility of 1,103 Candida spp. isolates from blood cultures, nonblood sterile samples, and nonsterile samples. Antifungal susceptibility was assessed by EUCAST E.Def 7.3.2; sequencing and genotyping of the FKS1-2 and ERG11 genes were carried out for non-wild-type isolates.